Chinese Biobank study KSCDC s u m m a r y Similar to many other developing countries, China is facing a double burden of disease as a result of epidemiological transition. Non-communicable diseases (NCDs) represent a major challenge, having an adverse effect on the health of the Chinese population and increasing the economic burden of health care. In today's era of evidence-based medicine and decision making, China, as a developing country, has a lack of local scientific evidence which will affect the effectiveness of NCD prevention and control.
study has a duration of 15e20 years, and will provide scientific evidence for strategic planning of NCD prevention and control, and development of new treatment and intervention approaches. In total, approximately 510,000 adults aged 30e79 years have been recruited from the general population in 10 geographically defined regions (five rural and five urban) of China, with differing disease profiles and differing risk exposures. Extensive data collection has been undertaken with questionnaires, physical measurements, and collection and storage of blood samples. KSCDC is a multi-factor, multi-disease, multidisciplinary large-scale chronic disease epidemiological study, and is also one of the largest long-term blood-based population cohort studies ever conducted in the world. It is worth mentioning that all gene specimens are kept in China, and all associated intellectual property rights are owned by international cooperation groups; this breaks new ground for Chinese and foreign international cooperation.
This article describes the study design, baseline description and main results to date. ª 2011 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Health transitions: The need for and challenge of medical services in urban and rural areas With urbanization, industrialization and strong economic growth in China, the Chinese population is undergoing rapid and profound health transitions. The life expectancy of different population groups (e.g. Guizhou, Gansu, Beijing, Shanghai etc.) has increased with increasing gross domestic product per head. There are also disparities in health, and significant differences exist between different population groups in China. Deaths from infectious diseases and total fertility have decreased, while deaths from non-communicable diseases (NCDs) have increased. Similar to other developing countries, China is facing a double burden of disease. Moreover, the prevalence of NCDs increased in both urban and rural areas from 1993 to 2008, and the number of people with major NCDs in China is expected to increase significantly from 2010 to 2030. 3, 4 Compared with 1993, the economic burden of disease in China increased 6.4-fold in 2005, while GDP growth increased 4.2-fold over the same period; the cost proportion of NCDs increased from 54% in 1993 to 65% in 2005. The total medical cost of NCDs was 1.48 trillion RMB (210 billion USD) in 2005. The proportion of the disease burden for NCDs increased from 54% in 1993 to 63% in 2005. Approximately 3.71 million premature deaths were caused by NCDs, accounting for 75% of all premature deaths in China. 5 If this trend continues, this will increase to 73% by 2020. This invisible epidemic is an under-appreciated cause of poverty, and hinders the economic development of many countries. The global epidemic of chronic diseases must be controlled effectively.
Risk factors: Focal points of disease prevention and intervention 
NCD prevention and control: Practice and research
In order to address the major challenge of NCDs, China is strengthening NCD prevention and control institutions and systems, including the Chinese Centre for Disease Control and Prevention, National Cancer Centre and National Centre for Cardiovascular Diseases, and will create a strong team for NCD control and prevention. 6 The Chinese Government issued a series of policy and technical documents for NCD control and prevention, such as the National Plan for Diabetes Prevention and Control 1996e2000, the National Plan for Cardiovascular and Cerebrovascular Diseases Prevention and Control 1996e2010, the National Plan for Tumour Prevention and Control 1986e2000, the National Plan for Cancer Prevention and Control 2004e2010, the National Standard for NCD Prevention and Control, and Standards on Nutrition. The Chinese Government has also developed a series of regulations to improve unhealthy diets, physical inactivity and tobacco use in recent years, and published various professional guidelines related to obesity and overweight, hypertension, dyslipidaemia and diet, etc. The CIH is a multinational programme of the Oxford Health Alliance for comprehensive community interventions, including China, India, Mexico and the UK in the pilot stage. 
Three main components in the design of the interventions are community coalition building, health communication and structural intervention. These combine to create communities in which healthy choices are easy choices. These measures will be implemented in four settings: schools, workplaces, community health centres and neighbourhoods. In addition to the CIH project, Hangzhou city happens to be undertaking some important changes at the same time which share the same aims as the CIH project to build a healthy city. One major initiative is Hangzhou public bicycle service, sponsored by the local government, which started on 1 May 2008. This complimentary bicycle rental system, as part of public transport, has been established in Hangzhou to solve the problem of the last 1 km from the bus stop to home or work. This programme effectively encourages active transportation, facilitates longterm behaviour changes when it comes to daily transportation, and, in turn, improve health.
The Chinese Biobank Study (Kadoorie Study of Chronic Disease in China) of 0.5 million people in China is a largescale, long-term follow-up cohort study to enhance the quality of relevant evidence in the Chinese population.
It is an open-ended study with broad research aims. A baseline survey (questionnaire, physical measurements and blood sample collection) was performed, and morbidity and mortality are being followed-up, with periodic resurveys of a sample of participants to help determine the main avoidable causes of NCDs in China. In total, approximately 510,000 adults aged 30e79 years have been recruited in 10 areas ( Figs. 1 and 2) . Cause-specific mortality data are obtained through death registries. Data on fatal or non-fatal events for ischaemic heart disease (IHD), stroke, diabetes and cancer are obtained through disease registries. At present, 3500 cases of IHD, 3500 cases of diabetes, 7000 strokes (75% confirmed by computer tomography/magnetic resonance imaging) and 8000 deaths have been reported in this cohort. There will be continuous long-term follow-up for a range of fatal and non-fatal conditions. The main findings include large unexplained variations in disease rate, co-existence of poverty and affluence, relatively wellestablished infrastructures, and high-quality survey data, with the ability to follow-up both fatal and non-fatal events and the potential to study very different ranges of risk exposures (e.g. blood lipids, body mass index and genes). The results will be relevant to the prediction, prevention and understanding of disease aetiology in China and other countries.
In conclusion, China's population is undergoing rapid and profound health transitions, and the burden of disease is increasing significantly. The major risk factors of NCDs are out of control if measures and interventions do not conduct immediately, and the potential risks are becoming more serious.The long-term health issues of Chinese people cannot be optimistic. The concept of NCD prevention and control is gradually changing, with more attention given to remote risk Fig. 1 e The location of the 10 survey sites in the Chinese Biobank Study. 
factors from disease with prevention measures extended to policy, environmental and economic approaches from medical treatment. NCD prevention and control has a long way to go.
